Compare ARK Genomic Revolution ETF (ARKG) vs Aterian Inc (ATER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Aterian Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.68, while Aterian Inc trades at $1.15 (market cap $12.44M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | ATER | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $1.45 |
52-Week Low | $23.09 | $0.54 |
Market Cap | — | $12.44M |
Enterprise Value | — | $13.02M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Aterian (ATER) trades at $1.15, down 3.36% with a bullish technical signal despite negative profitability. Revenue has declined from $221M in 2022 to $69M in 2025, with net losses narrowing but persisting. The company is pursuing an asset sale, with proxy advisors recommending stockholders vote for transactions expected to return $0.85-$1.14 per share. Analyst sentiment is split evenly between Buy and Hold ratings.
The outlook hinges on the successful asset sale providing shareholder returns, but fundamental challenges remain with sustained losses and cash burn. Investment opportunity exists in the potential special dividend, while risks include ongoing operational losses and competitive pressures in consumer products.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →
